Interfacial bonding in formulated bilayer tablets
- 1 February 2020
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 147, 69-75
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation (NNCI -1542202, 2017-2018)
- University of Minnesota (NNCI -1542202, 2017-2018)
This publication has 39 references indexed in Scilit:
- Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage formsPharmaceutical Development and Technology, 2012
- Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive AgentsHypertension, 2010
- Formulation and Evaluation of Bi-layer Tablet of Metoclopramide Hydrochloride and IbuprofenAAPS PharmSciTech, 2008
- Formulation and In Vitro Studies of a Fixed-Dose Combination of a Bilayer Matrix Tablet Containing Metformin HCl as Sustained Release and Glipizide as Immediate ReleaseDrug Development and Industrial Pharmacy, 2008
- Design and evaluation of sustained release bilayer tablets of propranolol hydrochlorideActa Pharmaceutica, 2007
- A material-sparing method for simultaneous determination of true density and powder compaction properties—Aspartame as an exampleInternational Journal of Pharmaceutics, 2006
- Compaction mechanism and tablet strength of unlubricated and lubricated (silicified) microcrystalline celluloseEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Hydroxypropylmethylcellulose sustained release technologyDrug Development and Industrial Pharmacy, 1989
- Percolation theory — a novel approach to solid dosage form designInternational Journal of Pharmaceutics, 1987
- Compression Strength of Porous Sintered Alumina and ZirconiaJournal of the American Ceramic Society, 1953